Trial Profile

A Randomized, Double-Masked, Vehicle-Controlled, Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution (VOS) in Subjects With Dry Eye Syndrome (DES)

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 12 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Jan 2021 Status changed from suspended to completed. Earlier, the company had suspended the development program for Voclosporin based upon the trial results.
02 Nov 2020 Status changed from active, no longer recruiting to suspended, according to an Aurinia Pharmaceuticals media release.
02 Nov 2020 According to an Aurinia Pharmaceuticals media release, further analysis of the AUDREY dataset will be conducted over the coming weeks. The company will host a conference call and webcast to discuss the trial results on Monday, November 2, 2020.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com